These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18028082)

  • 21. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.
    Schaeffer TH; Khatri V; Reifler LM; Lavonas EJ
    Acad Emerg Med; 2012 Feb; 19(2):121-31. PubMed ID: 22320362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic envenomation caused by the wandering spider Phoneutria nigriventer, with quantification of circulating venom.
    Bucaretchi F; Mello SM; Vieira RJ; Mamoni RL; Blotta MH; Antunes E; Hyslop S
    Clin Toxicol (Phila); 2008 Nov; 46(9):885-9. PubMed ID: 18788004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases.
    Açikalin A; Gökel Y; Kuvandik G; Duru M; Köseoğlu Z; Satar S
    Am J Emerg Med; 2008 May; 26(4):402-7. PubMed ID: 18410806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red back spider bite.
    Poolman C; Lai E; Qld W
    Aust Fam Physician; 2007 May; 36(5):295. PubMed ID: 17536253
    [No Abstract]   [Full Text] [Related]  

  • 25. Low incidence of early reactions to horse-derived F(ab')(2) antivenom for snakebites in Thailand.
    Thiansookon A; Rojnuckarin P
    Acta Trop; 2008 Feb; 105(2):203-5. PubMed ID: 17996842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redback spider bites in children in South Australia: A 10-year review of antivenom effectiveness.
    Cocks J; Chu S; Gamage L; Rossaye S; Schutz J; Soon AWC
    Emerg Med Australas; 2022 Apr; 34(2):230-236. PubMed ID: 34558205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of intramuscular antivenom in Red-back spider envenoming.
    Isbister GK
    Emerg Med (Fremantle); 2002 Dec; 14(4):436-9. PubMed ID: 12534488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance.
    Visser LE; Kyei-Faried S; Belcher DW; Geelhoed DW; van Leeuwen JS; van Roosmalen J
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):445-50. PubMed ID: 18190937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caution regarding Bier's block technique for redback spider bite.
    Winkel KD
    Med J Aust; 1999 Aug; 171(4):220-1. PubMed ID: 10494243
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum sickness from funnelweb spider antivenom.
    Miller MK; Whyte IM; Dawson AH
    Med J Aust; 1999 Jul; 171(1):54. PubMed ID: 10451679
    [No Abstract]   [Full Text] [Related]  

  • 31. [Systemic and local allergy to human insulin].
    Wittrup M; Pildal J; Rasmussen AK; Skov BG; Petersen J; Mandrup-Poulsen TR
    Ugeskr Laeger; 2003 May; 165(21):2207-8. PubMed ID: 12820512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venom and Antivenom of the Redback Spider (Latrodectus hasseltii) in Japan. Part II. Experimental Production of Equine Antivenom against the Redback Spider.
    Mori S; Horita A; Ginnaga A; Miyatsu Y; Sawabe K; Matsumura T; Ato M; Yamamoto A; Shibayama K; Arai S; Yamagishi T; Takahashi M; Taki H; Hifumi T
    Jpn J Infect Dis; 2017 Nov; 70(6):635-641. PubMed ID: 29093316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective review of snake bite victims.
    Nazim MH; Gupta S; Hashmi S; Zuberi J; Wilson A; Roberts L; Karimi K
    W V Med J; 2008; 104(5):30-4. PubMed ID: 18846756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case reports: type I hypersensitivity to lidocaine.
    Haugen RN; Brown CW
    J Drugs Dermatol; 2007 Dec; 6(12):1222-3. PubMed ID: 18189063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux.
    Harr T; Scherer K; Tsakiris DA; Bircher AJ
    Allergy; 2006 Jun; 61(6):787-8. PubMed ID: 16677252
    [No Abstract]   [Full Text] [Related]  

  • 36. Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin.
    Moloney FJ; Hughes R; O'Shea D; Kirby B
    Clin Exp Dermatol; 2008 Jul; 33(4):412-4. PubMed ID: 18498413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous Crotaline Fab antivenom for the treatment of rattlesnake envenomation in a porcine model.
    Offerman SR; Barry JD; Richardson WH; Tong T; Tanen D; Bush SP; Clark RF
    Clin Toxicol (Phila); 2009 Jan; 47(1):61-8. PubMed ID: 19153852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Undesirable reactions to local anesthetics and their treatment].
    van Beek H
    Ned Tijdschr Geneeskd; 1986 Jan; 130(3):131. PubMed ID: 3951600
    [No Abstract]   [Full Text] [Related]  

  • 39. [Two cases of early allergic reactions following a 1-shot intravenous administration of indocyanine green (ICG) and bromsulfophthalein (BSP)].
    Juszczyk J
    Wiad Lek; 1972 May; 25(10):907-12. PubMed ID: 5029356
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of immediate allergic reactions to cephalosporins in non-penicillin-allergic patients.
    Somech R; Weber EA; Lavi S
    Int Arch Allergy Immunol; 2009; 150(3):205-9. PubMed ID: 19494517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.